Trial · NCT01139762
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Washout and Placebo Lead-In Period | STARTED | Screening-Washout and Placebo Lead-In | 1,070 | |
| Washout and Placebo Lead-In Period | STARTED | Tadalafil | 0 | |
| Washout and Placebo Lead-In Period | STARTED | Placebo | 0 | |
| Washout and Placebo Lead-In Period | COMPLETED | Screening-Washout and Placebo Lead-In | 696 | |
| Washout and Placebo Lead-In Period | COMPLETED | Tadalafil | 0 | |
| Washout and Placebo Lead-In Period | COMPLETED | Placebo | 0 | |
| Washout and Placebo Lead-In Period | NOT COMPLETED | Screening-Washout and Placebo Lead-In | 374 | |
| Washout and Placebo Lead-In Period | NOT COMPLETED | Tadalafil | 0 | |
| Washout and Placebo Lead-In Period | NOT COMPLETED | Placebo | 0 | |
| Double-Blind Randomized Active Treatment | STARTED | Screening-Washout and Placebo Lead-In | 0 | |
| Double-Blind Randomized Active Treatment | STARTED | Tadalafil | 346 | |
| Double-Blind Randomized Active Treatment | STARTED | Placebo | 350 | |
| Double-Blind Randomized Active Treatment | Received at Least 1 Dose of Study Drug | Screening-Washout and Placebo Lead-In | 0 | |
| Double-Blind Randomized Active Treatment | Received at Least 1 Dose of Study Drug | Tadalafil | 345 | |
| Double-Blind Randomized Active Treatment | Received at Least 1 Dose of Study Drug | Placebo | 350 | |
| Double-Blind Randomized Active Treatment | COMPLETED | Screening-Washout and Placebo Lead-In | 0 | |
| Double-Blind Randomized Active Treatment | COMPLETED | Tadalafil | 306 | |
| Double-Blind Randomized Active Treatment | COMPLETED | Placebo | 286 | |
| Double-Blind Randomized Active Treatment | NOT COMPLETED | Screening-Washout and Placebo Lead-In | 0 | |
| Double-Blind Randomized Active Treatment | NOT COMPLETED | Tadalafil | 40 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01139762/flow